#Israel #Tel Aviv #financial results #Israel Corporation #ILCO

Israel Corporation Reports Q2 2026 Results

Israel Corporation Ltd. (TASE: ILCO), a major player in the Israeli market, has shared its financial outcomes for the second quarter that ended on June 30, 2026. The announcement, made on August 12, 2026, brings to light the company's performance driven by various factors, including equity earnings from subsidiaries such as ICL and Prodalim.

Summary of Financial Performance

The highlights from the financial report are as follows:

• - ILCO’s share in ICL profit: $59 million, an increase from $40 million in Q2 2025.
• - ILCO’s share in Prodalim’s net profit: $1 million, facing a slight reduction from $2 million the previous year.
• - The total net profit attributable to the company's shareholders increased to $53 million, compared to $43 million in the same quarter of the prior year.

The significant growth in net profit can be attributed to the robust performance of ICL, which continues to be a valuable asset in ILCO's portfolio.

Liquidity and Financial Position

As of the end of Q2 2026, total financial liabilities at ILCO headquarters reached $644 million, while investments in liquid assets amounted to $704 million. This reflects a healthy liquidity profile with net cash standing at $123 million, up from $100 million on March 31, 2026. The increase in net cash position incorporates the fair value from derivative transactions, reducing the economic value of financial liabilities by $63 million.

Asset Valuation

The total assets of Israel Corporation stood at $3.115 billion. The major contributors to this valuation include:

• - ICL shares (approximately 567 million shares) with a market value of $2.845 billion.
• - Prodalim Investments at $168 million for roughly 72 million shares.
• - AKVA Group shares valued at $86 million, and other investments totaling $16 million.

These figures highlight ILCO's substantial equity in both established and emerging markets, positioning the company favorably within its sector.

Recent Developments

Several pivotal events occurred prior to the announcement that are pertinent to understanding the company's trajectory. On February 24, 2026, Prodalim successfully concluded its IPO on the Tel Aviv Stock Exchange, raising approximately NIS 370 million and placing its valuation at about NIS 2.1 billion. Consequently, ILCO's stake in Prodalim was diluted from around 27.5% to approximately 23.26% on a fully diluted basis.

In March 2026, the ILCO Board approved a dividend distribution of approximately $13 million, aligning with the company’s policy, which was subsequently executed on April 27, 2026. Following that, a 10-to-1 share capital split was recommended and adopted during the General Meeting on July 13, 2026, coming into effect on July 27, 2026.

Looking Ahead

ILCO remains focused on strategic growth, guided by insights gained from recent performance reports. As emphasized in the company's forward-looking statements, management acknowledges the challenges and uncertainties inherent in the market but remains optimistic about leveraging its strengths and assets to capitalize on future opportunities.

For detailed information regarding ILCO's filings, stakeholders can refer to the Tel Aviv Stock Exchange website or visit the official ILCO company website.

Conclusion

Israel Corporation's Q2 results for 2026 illustrate a sound financial footing with improved profitability and liquidity, showcasing the company's potential in the competitive market landscape. As ILCO navigates forward, its strategic decisions and market positions will be critical in securing ongoing success in the evolving economic environment.